INTRODUCTION
Tissue organization during development requires the segregation of cells into different lineages and stage-and differentiationspecific intercellular adhesion of cells. There is, consequently, a great variety of specific cell-cell and cell-matrix interactions underlying these biological phenomena. Many different recognition molecules or cell surface adhesion receptors have been identified in recent years, which can be categorized into four major classes: (i) the cadherins, (ii) the immunoglobulin superfamily adhesion receptors, (iii) the selectins and (iv) the integrins (reviewed in ref. [1] ). Adhesion receptors are also probably important in the development and remodelling of bone. The cellular and molecular mechanisms of bone formation and regeneration, however, are as yet only poorly understood. Among known bone adhesion receptors, two subtypes of integrins are expressed in osteoclasts: the vitronectin receptor [2, 3] and the receptor for type I collagen [4, 5] . Osteoblasts express the type-I collagen receptor and the fibronectin receptor [6] , but little, if any, vitronectin receptor [7] . Several proteins containing the tripeptide recognition sequence RGD (Arg-Gly-Asp) [8, 9] , which is recognized by the vitronectin receptor [10, 11] , are constitutively expressed in osteoblasts and are found to be incorporated into the bone extracellular matrix, where osteoclasts bind to them. Among these proteins are osteopontin [12, 13] , thrombospondin [14, 15] , fibronectin [16] and laminin [17] . The receptor profile of osteoclasts differs from other haemopoietic cell types and may reflect a specialized role in bone. In contrast, the integrins on osteoblasts do not seem to differ radically from other stromal or fibroblastic cells. It has been speculated that unidentified homophilic receptors should be expressed on osteofascicin I. RNA analyses revealed that OSF-2 is expressed in bone and to a lesser extent in lung, but not in other tissues. Mouse OSF-2 cDNA was subsequently used as a probe to clone the human counterpart. Mouse and human OSF-2 show a high amino acid sequence conservation except for the signal sequence and two regions in the C-terminal domain in which 'in-frame' insertions or deletions are observed, implying alternative splicing events. On the basis of the amino acid sequence homology with fascicin I, we suggest that OSF-2 functions as a homophilic adhesion molecule in bone formation.
clasts and osteoblasts during early stages ofmesenchymal differentiation and pattern formation in the embryo [7] . Such homophilic receptors, however, have not yet been described for bone cells.
Here we describe the isolation and characterization of mouse and human cDNA encoding a new potential bone adhesion protein, which we name osteoblast-specific factor 2 (OSF-2) (a previously described factor was named OSF-1, see ref. [18] ). Computer analysis of the deduced primary amino acid sequence of OSF-2 revealed a complex protein structure with a characteristic fourfold-repeated domain. A similar structure has been reported for the insect protein fasciclin I, a protein implicated in neuronal cell-cell adhesion [19] [20] [21] [22] [23] and sequence similarity between OSF-2 and fasciclin I within the repeat domain was detected. The expression of OSF-2 mRNA in the mouse calvarial osteoblastic cell line MC3T3-El is regulated by osteotrophic factors. OSF-2 is highly conserved between mouse and human and we speculate that this protein acts as a homophilic adhesion molecule in bone formation.
MATERIALS AND METHODS
MC3T3-E1 subtraction library construction and screening MC3T3-El and NIH3T3 poly(A)+ RNA was isolated as described [18] . Solution hybridization of MC3T3-El cDNA and photobiotinylated poly(A)+ RNA from NIH3T3 cells was performed according to the 'subtractor IIF protocol (Invitrogen). The double-stranded subtracted MC3T3-E1 cDNA was ligated with EcoRI/NotI adaptors (Pharmacia) and cloned into AgtlO (Stratagene). Recombinant phages of the subtracted MC3T3-El library (1 x 104) were rescreened by differential plaque hybridization (first round screening) employing cDNA probes prepared from mRNA isolated from MC3T3-El and NIH3T3 cells as described [18] . MC3T3-El-specific clones (155) were plaqueisolated, and cDNA inserts from these clones were amplified by PCR [24] . The PCR fragments were isolated, radiolabelled and used as probes to perform MC3T3-E1 and NIH3T3 RNA dotblot analysis (second round screening). PCR fragments giving positive hybridization signals with MC3T3-E1 RNA, but negative signals with NIH3T3 RNA, were recloned into pUC118 (Takara Shuzo Company) or pHSG398 [25] .
Screening of human cDNA libraries
The human osteosarcoma tissue cDNA library (in AZaplI) was a gift from Michael Kiefer (Chiron Co., Emeryville, CA, U.S.A.) [26] . A human placenta cDNA library (in Agtl 1) was purchased from Clontech. Using the mouse OSF-2 cDNA insert of MC 163 as a hybridization probe, both human cDNA phage libraries were screened: 72 positive clones from the placenta library and 31 positive clones from the osteosarcoma library were obtained. The seven plaques with the strongest signals from the placenta library and the five plaques with the strongest signals from the osteosarcoma library were amplified and their respective EcoRI or BglII inserts were isolated. The largest insert of each type was cloned into pUC1 18 and pHSG398 respectively, and the resulting plasmids were named pKOT133 and pKOT158.
RNA dot blot and Northern blot
Total RNAs from mouse tissues were purified by the guanidinium thiocyanate method [27] . Heat-denatured total RNA (1 jug) was dotted on to nylon membrane filters (Biodyne, Pall), and hybridization with 32P-labelled cDNA fragments was performed. Northern-blot analysis with 1 g of cytoplasmic RNA/lane was performed using a 1.2 % formaldehyde/agarose gel. After electrophoresis, RNA was blotted on to a nylon filter, and hybridization with the randomly primed mouse OSF-2 cDNA probe was performed using standard procedures [27] . Genomic Southernblot analysis was performed as described [27] .
DNA sequencing and protein analysis
The nucleotide sequences of the cDNA inserts were determined by the dideoxy chain-termination method [28] using the automatic DNA sequence analyser, model 373A from Applied Biosystems. The nucleotide sequence of the entire coding region was determined by sequencing both strands. Nucleotide and amino acid sequence homology search was performed through the GeneBank DNA database (release 71.0) and NBRF protein database (release 32.0), utilizing the FastA and TfastA programs of GCG sequence analysis software package [29] .
Cell cultures MC3T3-E1 cells [30] were grown in the presence of 10% fetal calf serum (FCS) 
RESULTS

Cloning of mouse OSF-2 cDNA
Employing a subtraction hybridization/differential screening approach, 22 cDNA clones were isolated from the mouse calvarial osteoblastic cell line MC3T3-E1, which hybridized with MC3T3-El RNA, but not with NIH3T3 RNA. These cDNA clones could be classified into six groups according to their mouse tissue RNA dot-blot hybridization pattern and were partially sequenced (not shown). The largest group consisted of 15 individual clones with cDNA inserts having similar restriction enzyme patterns (the other groups contained cDNA encoding different osteoblastspecific proteins and will be described elsewhere). The clone with the longest insert, MC163, was sequenced. The entire nucleotide sequence and the deduced amino acid sequence of mouse OSF-2 is shown in Figure 1 Figure 2 . A fourfold internal repeat composed of approx. 130 amino acids each follows the cysteine-rich region and precedes the 178-residuelong C-terminal region. Each of the four internal repeat units contains two particularly conserved regions of 13 and 14 amino acids each (see below). Whereas the overall sequence similarity between the repeated units is relatively low (23.2 % amino acid identity on average), the sequence similarity between the two particularly conserved regions is high (61.5 % and 45.2 % amino acid identity on average). mRNA detection, gene copy determination and tissue-speciflc expression of mouse OSF-2
Northern-blot analysis revealed the presence of a single mRNA band of approx. 3.4 kb in MC3T3-E1 cells (Figure 3 ), which corresponds well to the size of the cloned cDNA of 3187 bp. Addition of FCS to the growth medium represses the amount of detectable OSF-2 mRNA ( Figure 3 ; see also below). Southernblot analysis employing different washing stringencies showed that the OSF-2 gene is present as a single-copy gene in the mouse genome ( Figure 4) .
In order to examine the tissue-specific expression of OSF-2, RNA dot-blot analysis was performed. Figure 5 Figure 1 Nucleotide and predicted amino acid sequences of mouse OSF-2
The nucleotide sequence of the cDNA insert from clone pMC1 63 was determined from both strands. The deduced amino acid sequence is displayed below the DNA sequence. Numbering of amino acids is relative to the N-terminal methionine (position 1). The solid arrowhead indicates the putative signal sequence-cleavage site inferred as described by von Heijne [31] . The potential At glycosylation site is underlined. The boxed areas indicate the weakly conserved fourfold-repeat domains of OSF-2 and correspond to domains Rl, R2, R3 and R4 in Figure 2 (Figure 6 ). FCS, epidermal growth 
OSF-2
The shaded area at the N-terminus indicates the signal sequence. Rl, R2, R3 and R4 indicate the fourtold-repeating domains, followed by the C-terminal domain. C denotes the position of cysteines and the arrow indicates a potential Nglycosylation site. Stippled and solid boxes show the two particularly well conserved regions (corresponding to the boxed areas in Figure 8 ). Figure 7 shows the alignment of the deduced amino acid sequences of mouse and human OSF-2 proteins. Compared with mouse OSF-2, hOSF2os has an insertion of 27 amino acids and hOSF-2pl has a deletion of 57 amino acids within the C-terminal domain. Partial sequencing of three other independently derived clones from both libraries (two from the placenta and one from the osteosarcoma library) revealed a second site (residues 785-812 in Figure 7 ) within the C-terminal domain at which variations are observed. Cells were seeded, preincubated and treated with the indicated factors at the indicated concentrations for 24 h. RNA was extracted and dot-blot hybridization was performed as described in the Materials and methods sections. 'FCS(10%)*', cells were treated as described in the legend to Figure 3 , lane 1; 'medium only', cells were treated as described in the legend to Figure 3 , lane 2; 'FCS(10%)*', cells were treated as described in the legend to Figure 3 , lane 3. Hybridization probes were the same as described in the legend to Figure 4 . The presence (+) or absence (-) Figure 8 Comparison of the conserved repeat sequences in mouse OSF-2 and Drosophila fasciclin Position number of the first and last residue of each domain is given in parentheses after each sequence; position number 1 corresponds to the first methionine. Gaps (.) were introduced to get maximum sequence similarity using the Pileup program of GCG [29] . Amino acid residues identical in at least four positions are indicated in the line of consensus sequence. Two particularly conserved regions are boxed. dFas-1, Drosophila fasciclin [19] . Rl, R2, R3 and R4 correspond to the fourfold repeat domains indicated in Figures 1 and 2 .
Cloning of a novel osteoblast-specific protein 277 Structural similarity of OSF-2 to the Insect protein fasciclin I Database homology search using the whole mouse OSF-2 sequence did not shown any significant sequence similarity to other known proteins, but by limiting the query sequence to the conserved regions, the search revealed sequence similarity to fasciclin I (Figure 8 ). Fasciclin I has a similar protein organization to OSF-2. It also has a fourfold repeat structure of similar size (approx. 150 amino acids each) with weak sequence similarity (7-15 % identity) with each other including highly conserved amino acid 'regions' (up to 45% identity between regions) within the fourfold repeat structure [19] . The two particularly conserved regions (see Figure 8) found in OSF-2 are well conserved in fascicin I. The amino acid sequence identity between these two particularly conserved regions of OSF-2 and fasciclin I is 41.4 % and 43.3 % on average respectively. In addition, weak sequence similarity is observed for the entire fourfold repeat structure of OSF-2 and fasciclin I (Figure 8 Using the mouse OSF-2 cDNA as a probe, human osteosarcoma and placental libraries were screened. Many positive clones were isolated, indicating that OSF-2 cDNA is abundantly present in these libraries. One complete human OSF-2 cDNA from each library was characterized in detail. Except for a variation within the C-terminal domain, the deduced amino acid sequences of both human OSF-2 proteins are identical. Subsequently, three further human OSF-2 cDNA clones were analysed and a second site of variability within the C-terminal domain was identified. In total, five different forms of human OSF-2 were isolated. All differences constitute in-frame deletions or insertions, implying alternative splicing events. The reason for the high degree of variability is at present unknown, but it is interesting to note that all splicing events occur within the Cterminal domain, indicating that the other protein domains might be essential for the biological role of OSF-2.
Mouse and human OSF-2 are highly conserved. The common protein structure shows a typical signal sequence, followed by a cysteine-rich domain, a fourfold repeated domain and a Cterminal domain, but lacks a transmembrane region. Alignment of each repeat unit reveals that there are two particularly conserved regions of 13 and 14 amino acids each (Figure 8 ).
Computer search revealed amino acid similarity between OSF-2 and fascicin I, a homophilic adhesion protein involved in the neuron growth cone guidance during development of Drosophila and grasshopper embryos [19] [20] [21] [22] [23] . Fascicin I and OSF-2 have a similar protein structure organization, characterized by a weakly conserved fourfold repeat structure. Each repeat has approx. 130 amino acids in OSF-2 and approx. 150 amino acids in fasciclin I. Within each of the fourfold repeat units, two particularly conserved regions are located in which the strong similarity between OSF-2 and fasciclin I is observed. Neither OSF-2 nor fasciclin I possess typical transmembrane domains. Based on these similarities and the amino acid sequence similarity, we suggest that OSF-2 and fascicin I are derived from a common ancestor and have similar protein structures and functions.
Fasciclin I has a glycosylphosphatidylinositol lipid moiety [22] which facilitates membrane association (reviewed in [38, 39] ). We could not detect a potential glycosylphosphatidylinositol membrane anchor site at the corresponding region of OSF-2. However, when we analysed the C-terminal sequence of mouse OSF-2 by the methods of Berzofsky et al. [40] and Vogel and Jahnig [41] , one site possibly involved in the formation ofan amphipathic a-helix (residues 774-795 in Figure 7 ) and two sites possibly involved in the formation of fl-strands (residues 806-815 and 819-829 in Figure 7 ) were found. These sites might be involved in the membrane association and may compensate for the lack of a glycosylphosphatidylinositol membrane anchor sequence.
The five different forms of human OSF-2 cDNA, probably the result of alternative splicing, may encode membrane-bound and secreted variants of the protein. This is conceivable, since all five splicing events occurred in the C-terminal domain leaving the fourfold repeat structure unchanged. Alternatively, the splicing may alter the binding specificity of OSF-2, as has been suggested in the case of fasciclin I [23] . The alternative splicing in fasciclin I, however, results in variation in the second repeat unit and therefore might not serve as a model to explain the biological relevance of alternative splicing of OSF-2. More experiments are needed to ascertain the detailed biological role of OSF-2.
